Sun Pharma Advanced Research Company share news, announcements and annual reports
NSE: SPARCBSE: 532872Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹182.98.
30 Oct: open ₹183.90, high ₹183.90, low ₹175.25
- Next results date: the board meets on 2 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,727 Cr778th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 3.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.28
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 118.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 84.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,50,81840.4% delivered
Sun Pharma Advanced Research Company routine notices
154 filed, newest first. Page 2 of 4.
Oct 2023
10 Oct · Routine
9 Oct · Routine
6 Oct · Routine
Sep 2023
22 Sep · Routine
1 Sep · Routine
Aug 2023
28 Aug · Routine
11 Aug · Routine
11 Aug · Routine
Jul 2023
15 Jul · Routine
14 Jul · Routine
13 Jul · Routine
7 Jul · Routine
3 Jul · Routine
Jun 2023
May 2023
Apr 2023
28 Apr · Routine
18 Apr · Routine
14 Apr · Routine
Mar 2023
14 Mar · Routine
10 Mar · Routine
Feb 2023
24 Feb · Routine
18 Feb · Routine
17 Feb · Routine
15 Feb · Routine
Jan 2023
27 Jan · Routine
20 Jan · Routine
20 Jan · Routine
12 Jan · Routine
5 Jan · Routine
Dec 2022
29 Dec · Routine
Nov 2022
10 Nov · Routine
Oct 2022
21 Oct · Routine
Sep 2022
29 Sep · Routine
13 Sep · Routine
6 Sep · Routine
1 Sep · Routine
Aug 2022
23 Aug · Routine